Proteon Therapeutics to Participate in Two Upcoming Investor Conferences
09 nov. 2016 16h35 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces Third Quarter 2016 Financial Results
07 nov. 2016 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Appoints Paul Hastings Chairman of Its Board of Directors
20 oct. 2016 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics to Present at Two Upcoming Investor Conferences
01 sept. 2016 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces Second Quarter 2016 Financial Results
08 août 2016 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces First Quarter 2016 Financial Results
09 mai 2016 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., May 09, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces Survey Findings Demonstrating Impact of Vascular Access Failure on Hemodialysis Patients
28 avr. 2016 07h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., April 28, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2015 Financial Results
14 mars 2016 08h30 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 14, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference on March 8th
02 mars 2016 17h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 02, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics to Present at the Oppenheimer 26th Annual Healthcare Conference December 9th
02 déc. 2015 08h00 HE
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...